Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by FredTheVoiceon Jun 11, 2018 10:42am
320 Views
Post# 28154074

Evidence and shorting

Evidence and shorting
PALINC just wrote that he is surpised that horses dont talk. Well Well. Some on this board will not respond to him, but think behind their computer: "This guy is funny, we just got the annual meeting with the horses screaming out loud that we just reached 100 patients.......TAIMED saying that the demand is stronger that they initially expected.....and he is saying that horses dont talk ?" ....What arre you waiting for ? A press release every morning ? Roosters sing every morning..........Horses talk when its time. AND THEY DID !

Jay Jay puts ahead a theory about maybe firms shorting TH fo a total of more than 3 MILIONS shares to buy those notes..........well, no evidence of that on the market in the past few days........yes volume is great. OK. But my guess is that some are ready to put money in the notes without selling to many shares. And if they want to sell over 3 milions shares........they must do it fast, because the closing of that offer is settled for june 19. Thats very soon. And JAY JAY, your other theory I hope is good: the share price will, after june 19.........go UP UP...!

Good day, and lets hope the horses will talk so we can understand very clearly........in july !

FTV.
Bullboard Posts